Skip to main content
SpringerLink
Log in

Rotavirus Vaccines

  • Chapter
Combination Vaccines

Abstract

There are two candidate rotavirus vaccines that consist of a combination of four or more viral strains. Each of the two candidate vaccines is made by genetically reassorting one animal rotavirus strain (i.e., simian or bovine) with each of several human rotavirus strains. The resultant reassortant strains retain the attenuated virulence characteristics of the animal strains and express one of the genes that encode the proteins that determine human rotavirus serotype. It is estimated that the simian × human reassortant rotavirus vaccine could be licensed by the Food and Drug Administration (FDA) and recommended for universal use in all infants by the Advisory Committee on Immunization Practices in 1998. Strategies used to formulate, construct, and combine animal × human rotavirus reassortant vaccines as well as selected aspects of rotavirus immunology, molecular biology, and pathogenesis will be described in this chapter. Since the rotavirus vaccine is itself a multivalent combination vaccine, issues related to the interactions among different serotype viruses will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. De Zoysa, I. and Feachem, R. G. (1985) Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization. Bull. WHO 63, 569–583.

    PubMed  Google Scholar 

  2. Kapikian, A. Z. and Chanock, R. M. (1996) Rotaviruses, in Fields Virology, 3rd ed., vol. 2 (Fields, B. N., Knipe, D. M., Howley, P. M., Chanock, R. M., Melnick, J. L., Monath, T. P., Roizman, B., and Straus, S. E., eds.), Lippincott-Raven, Philadelphia, pp. 1657–1708.

    Google Scholar 

  3. Glass, R. I., Kilgore, P. E., Holman, R. C., et al. (1996) The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. J. Infect. Dis. 174(Suppl. 1), S5—S 11.

    Google Scholar 

  4. Kilgore, P. E., Holman, R. C., Clarke, M. J., and Glass, R. I. (1995) Trends of diarrheal disease-associated mortality in U. S. children, 1968 through 1991. JAMA 274, 1143–1148.

    CAS  PubMed  Google Scholar 

  5. Huilan, S., Zhen, L. G., Mathan, M. M., et al. (1991) Etiology of acute diarrhoea among children in developing countries: a multicenter study in five countries. Bull. WHO 69, 549–555.

    Google Scholar 

  6. Levine, M. M., Losonsky, G., Herrington, D., et al. (1986) Pediatric diarrhea: the challenge of prevention. Pediatr. Infect. Dis. 5, S29 - S43.

    CAS  PubMed  Google Scholar 

  7. Cook, S. M., Glass, R. I., LeBaron, C. W., and Ho, M.-S. (1990) Global seasonality of rotavirus infections. Bull. WHO 68, 171–177.

    CAS  PubMed  Google Scholar 

  8. Bern, C., Martines, J., deZoysa, 1., and Glass, R. I. (1992) The magnitude of the global problem of diarrhoeal disease: a ten year update. Bull. WHO 70, 705–714.

    CAS  Google Scholar 

  9. Murray, C. J. and Lopez, A. D. (1997) Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349, 1436–1442.

    CAS  PubMed  Google Scholar 

  10. Walsh, J. A. and Warren, K. S. (1979) Selective primary health care. An interim strategy for disease control in developing countries. N. Engl. J. Med. 301, 967–974.

    CAS  PubMed  Google Scholar 

  11. Snyder, J. D. and Merson, M. H. (1982) The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data. Bull. WHO 60, 605–613.

    CAS  PubMed  Google Scholar 

  12. Tallett, S., MacKenzie, C., Middleton, P., et al. (1977) Clinical, laboratory, and epidemiologic features of a viral gastroenteritis in infants and children. Pediatrics 60, 217–222.

    CAS  PubMed  Google Scholar 

  13. Carr, M., McKendrick, D., and Spyridakis, T. (1978) The clinical features of infantile gastroenteritis due to rotavirus. Scand. J. Infect. Dis. 8, 241–243.

    Google Scholar 

  14. Kovacs, A., Chan, L., Hotrakitya, C., et al. (1987) Rotavirus gastroenteritis: clinical and laboratory features and use of the rotazyme test. Am. J. Dis. Child. 141, 161–166.

    CAS  PubMed  Google Scholar 

  15. Rodriguez, W., Kim, H., Arrobio, J., et al. (1977) Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children. J. Pediatr. 91, 188–193.

    CAS  PubMed  Google Scholar 

  16. Estes, M. (1996) Rotaviruses and their replication, in Field’s Virology, 3rd ed., vol. 2 ( Fields, B. N., Knipe, D. M., and Howley, P. M., eds.), Lippincott-Raven, Philadelphia, pp. 1625–1655.

    Google Scholar 

  17. Hoshino, Y., Sereno, M. M., Midthun, K., et al. (1985) Independent segregation of two antigenic specificities (vp3 and vp 7) involved in neutralization of rotavirus infectivity. Proc. Natl. Acad. Sci. USA 82, 8701–8704.

    CAS  PubMed  Google Scholar 

  18. Offit, P. A. and Blavat, G. (1986) Identification of the two rotavirus genes determining neutralization specificities. J. Virol. 57, 376–378.

    CAS  PubMed  Google Scholar 

  19. Offit, P. A., Clark, H. F., Blavat, G., and Greenberg, H. B. (1986) Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. J. Virol. 60, 491–496.

    CAS  PubMed  Google Scholar 

  20. Midthun, K., Greenberg, H. B., Hoshino, Y., et al. (1985) Reassortant rotaviruses as potential live rotavirus vaccine candidates. J. Virol. 53, 949–954.

    CAS  PubMed  Google Scholar 

  21. Kalica, A. R., Greenberg, H. B., Wyatt, R. G., et al. (1981) Genes of human (strain WA) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology 112, 385–390.

    CAS  PubMed  Google Scholar 

  22. Larralde, G., Li, B., Kapikian, A. Z., and Gorziglia, M. (1991) Serotype-specific epitopes present on the vp 8 subunit of rotavirus vp 4 protein. J. Virol. 65, 3213–3218.

    CAS  PubMed  Google Scholar 

  23. Gorziglia, M. K. Y., Green, K., Nishikawa, K., et al. (1988) Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J. Virol. 62, 2979–2984.

    Google Scholar 

  24. Mebus, C. A., Stair, E. L., Underdahl, N. R., and Twiehaus, M. J. (1974) Pathology of neonatal calf diarrhea induced by a reo-like virus. Vet. Pathol. 8, 490–505.

    Google Scholar 

  25. Pearson, G. R. and McNulty, M. S. (1977) Pathological changes in the small intestine of neonatal pigs infected with a pig reovirus-like agent (rotavirus). J. Comp. Pathol. 87, 363–375.

    CAS  PubMed  Google Scholar 

  26. Snodgrass, D. R., Ferguson, A., Allan, F., et al. (1979) Small intestinal morphology and epithelial cell kinetics in lamb rotavirus infections. Gastroenterology 76, 477–481.

    CAS  PubMed  Google Scholar 

  27. Starkey, W. G., Collins, J., Wallis, T. S., et al. (1986) Kinetics, tissue specificity and pathological changes in murine rotavirus infection of mice. J. Gen. Virol. 67, 2625–2634.

    PubMed  Google Scholar 

  28. Holmes, I. H., Ruck, B. J., Bishop, R. F., and Davidson, G. P. (1975) Infantile enteritis viruses: morphogenesis and morphology. J. Virol. 16, 937–943.

    Google Scholar 

  29. Suzuki, H. and Konno, T. (1975) Reovirus-like particles in jejunal mucosa of a Japanese infant with acute infectious non-bacterial gastroenteritis. Tohoku J. Exp. Med. 115 199–211.

    Google Scholar 

  30. Sheridan, J. F., Eydelloth, R. S., Vonderfecht, S. L., and Aurelian, L. (1983) Virus-specific immunity in neonatal and adult mouse rotavirus infection. Infect. Immun. 39, 917–927.

    Google Scholar 

  31. Ball, J. M., Tian, P., Zeng, C. Q. Y., et al. (1996) Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 272, 101–104.

    CAS  PubMed  Google Scholar 

  32. Angel, J., Tang, B., Feng, N., et al. (1998) Studies of the role for NSP4 in pathogenesis of homologous murine rotavirus diarrhea. J. Infect. Dis. 177, 455–458.

    CAS  PubMed  Google Scholar 

  33. Hoshino, Y., Sereno, M. M., Kapikian, A. Z., et al. (1993) Genetic determinants of rotavirus virulence studied in gnotobiotic piglets, in Vaccines ’93. Cold Spring Harbor Laboratory, pp. 277–282.

    Google Scholar 

  34. Bishop, R., Barnes, G., Cipriani, E., and Lund, J. (1983) Clinical immunity after neonatal rotavirus infection: a prospective longitudinal study in young children. N. Engl. J. Med. 309, 72–76.

    CAS  PubMed  Google Scholar 

  35. Bernstein, D. I., Sander, D. S., Smith, V. E., et al. (1991) Protection from rotavirus reinfection: 2-year prospective study. J. Infect. Dis. 164, 277–283.

    CAS  PubMed  Google Scholar 

  36. Ward, R. L. and Bernstein, D. (1994) Protection against rotavirus disease after natural infection. J. Infect. Dis. 169, 900–904.

    CAS  PubMed  Google Scholar 

  37. Matson, D. O., O’Ryan, M. L., Herrera, I., et al. (1993) Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. J. Infect. Dis. 167, 577–583.

    Google Scholar 

  38. Coulson, B., Grimwood, K., Hudson, I., et al. (1992) Role of coproantibody in clinical protection of children during reinfection with rotavirus. J. Clin. Microbiol. 30, 16781684.

    Google Scholar 

  39. O’Ryan, M. L., Matson, D. O., Estes, M. K., and Pickering, L. K. (1994) Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infection. J. Infect. Dis. 169, 504–511.

    PubMed  Google Scholar 

  40. Yolken, R., Wyatt, R., and Zissis, G. (1978) Epidemiology of human rotavirus types 1 and 2 as studied by enzyme-linked immunosorbent assay. N. Engl. J. Med. 299, 1156–1161.

    CAS  PubMed  Google Scholar 

  41. Black, R., Greenberg, H., Kapikian, A., et al. (1982) Acquisition of serum antibody to Norwalk virus and rotavirus in relation to diarrhea in a longitudinal study of young children in rural Bangladesh. J. Infect. Dis. 145, 483–489.

    Google Scholar 

  42. Mata, L., Simhon, A., Urratia, J., et al. (1983) Epidemiology of rotaviruses in a cohort of 45 Guatemalan Mayan Indian children observed from birth to the age of three years../. Infect. Dis. 148, 452–461.

    CAS  Google Scholar 

  43. Chiba, S., Nakata, S., Urasawa,T., et al. (1986) Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet i, 417–421.

    Google Scholar 

  44. Linhares, A., Gabbay, Y., Mascarenhas, J., et al. (1988) Epidemiology of rotavirus subgroups and serotypes in Belem, Brazil: a three-year study. Ann. Inst. Pasteur./Virol. 139, 89–99.

    CAS  Google Scholar 

  45. Georges-Courbot, M., Monges, J., Beraud-Cassel, A., et al. (1988) Prospective longitudinal study of rotavirus infections in children from birth to two years of age in Central Africa. Ann. Inst. Pasteur./Virol. 139, 421–428.

    CAS  Google Scholar 

  46. Friedman, M., Gaul, A., Sarov, B., et al. (1988) Two sequential outbreaks of rotavirus gastroenteritis: evidence for symptomatic and asymptomatic reinfection. J. Infect. Dis. 158, 814–822.

    CAS  PubMed  Google Scholar 

  47. Grinstein, S., Gomez, J., Bercovich, J., and Biscorn, E. (1989) Epidemiology of rotavirus infection and gastroenteritis in prospectively monitored Argentine families with young children. Am. J. Epidemiol. 130, 300–308.

    CAS  PubMed  Google Scholar 

  48. Reyes, R., Hossain, M., Midthun, K., et al. (1989) An observational study of naturally-acquired immunity in a cohort of 363 Egyptian children. Am. J. Epidemiol. 130, 981–988.

    Google Scholar 

  49. O’Ryan, M., Matson, D., Estes, M., et al. (1990) Molecular epidemiology of rotavirus in young children attending day care centers in Houston. J. Infect. Dis. 162, 810–816.

    PubMed  Google Scholar 

  50. DeChamps, C., Laveran, H., Peigue-Lafeville, J., et al. (1991) Sequential rotavirus infections: characterization of serotypes and electropherotypes. Res. Virol. 142, 39–45.

    CAS  Google Scholar 

  51. Madore, H., Christy, C., Pichichero, M., et al. (1992) Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of vp7 serotype 3 or 1 specificity in infants. J. Infect. Dis. 166, 235–243.

    CAS  PubMed  Google Scholar 

  52. Bernstein, D., Glass, R., Rodgers, G., et al. (1995) Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in United States children. JAMA 273, 1191–1196.

    CAS  PubMed  Google Scholar 

  53. Ward, R. and Bernstein, D. (1995) Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. Vaccine 13, 1226–1252.

    CAS  PubMed  Google Scholar 

  54. Offit, P. A. and Dudzik, K. I. (1989) Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection. J. Virol. 63, 3507–3512.

    CAS  PubMed  Google Scholar 

  55. Offit, P. A. and Dudzik, K. I. (1990) Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice. J. Viral. 64, 6325–6328.

    CAS  Google Scholar 

  56. Dharakul, T., Rott, L., and Greenberg, H. B. (1990) Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes. J. Viral. 64, 4375–4382.

    CAS  Google Scholar 

  57. Franco, M., Tin,C., and Greenberg, H. (1997) CD8+ T cells can mediate complete short term and partial long term protection against reinfection by rotavirus. J. Viral. 71, 4165–4170.

    CAS  Google Scholar 

  58. Matsui, S., Mackow, E., and Greenberg, H. (1989) Molecular determinants of rotavirus neutralization and protection. Adv. Virus. Res. 36, 181–214.

    CAS  PubMed  Google Scholar 

  59. Clark, H. F., Borian, F. E., Bell, L. M., et al. (1988) Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J. Infect. Dis. 158, 570–587.

    CAS  PubMed  Google Scholar 

  60. Matson, D., O’Ryan, M., Pickering, L., et al. (1992) Characterization of serum antibody responses to natural rotavirus infections in children by vp7-specific epitope-blocking assays. J. Clin. Microbial. 30, 1056–1061.

    CAS  Google Scholar 

  61. Zheng, B., Han, S., Yan, Y., et al. (1988) Development of neutralizing antibodies and group A common antibodies against natural infections with human rotavirus. J. Clin. Microbial. 26, 1506–1512.

    CAS  Google Scholar 

  62. Puerto, F., Padilla-Noriega, L., Zamora-Chavez, A., et al. (1987) Prevalent patterns of serotype-specific seroconversion in Mexican children infected with rotavirus. J. Clin. Microbial. 25, 960–963.

    CAS  Google Scholar 

  63. Gerna, G., Sarasini, A., Torsellini, M., et al. (1990) Group-and type-specific serologic response in infants and children with primary rotavirus infections and gastroenteritis caused by a strain of known serotype. J. Infect. Dis. 161, 1105–1111.

    CAS  PubMed  Google Scholar 

  64. Clark, H., Dolan, K., Horton-Slight, P., et al. (1985) Diverse serologic response to rotavirus infection of infants in a single epidemic. Pediatr. Infect. Dis. 4, 626–631.

    CAS  PubMed  Google Scholar 

  65. Mebus, C. A., White, R. G., Bass E. P., and Twiehaus, M. J. (1973) Immunity to neonatal calf diarrhea virus. JAVMA 163, 880–883.

    Google Scholar 

  66. Saif, L. and Fernandez, F. (1996) Group A rotavirus veterinary vaccines. J. Infect. Dis. 174, S98—S 106.

    Google Scholar 

  67. Vesikari, T., Isolauri, E., D’Hondt, E., et al. (1984) Protection of infants against rotavirus diarrhea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1, 977–980.

    CAS  PubMed  Google Scholar 

  68. Flores, J., Perez-Schael, I., Gonzalez, M., et al. (1987) Protection against severe rotavirus diarrhea by rhesus rotavirus vaccine Venezuelan children. Lancet 1, 882–884.

    CAS  PubMed  Google Scholar 

  69. Gothefors, L., Wadell, G., Juto, P., et al. (1989) Prolonged efficacy of rhesus rotavirus vaccine in Swedish children. J. Infect. Dis. 159, 753–757.

    CAS  PubMed  Google Scholar 

  70. Georges-Coubot, M. C., Monges, J., Siopathis, M. R., et al. (1991) Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res. Virol. 142, 405–411.

    Google Scholar 

  71. Ogra, P. L. (1996) Mucosal immunoprophylaxis: an introductory overview, in Mucosal Vaccines ( Kiyono, H., Ogra, P. L., and McGhee, J. R., ed.), Academic, New York, NY, pp. 3–14.

    Google Scholar 

  72. Clark, H. F., Shrager, D., Lawley, D., Offit, P. A., and Ellis, R. Human-bovine G1 reassortant of rotavirus WC3: dose response patterns to vp7 (G1) and vp 4 (P5 [7]) are distinct. Vaccine (submitted for publication).

    Google Scholar 

  73. Garbag-Chenon, A., Fontaine, J.-L., Lasfargues, G., et al. (1989) Reactogenicity and immunogenicity of rotavirus WC3 vaccine in 5–12-month-old infants. Res. Virol. 140, 207–217.

    CAS  PubMed  Google Scholar 

  74. Kapikian, A., Hoshino, Y., Chanock, R., and Perez-Schael, I. (1996) Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J. Infect. Dis. 174, S65 - S72.

    Google Scholar 

  75. Clark, H. F., Offit, P., Ellis, R., et al. (1996) The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants.. 1. Infect. Dis. 174, S73 - S80.

    Google Scholar 

  76. Wyatt, R. G., Mebus, C. A., Yolken, R. H., et al. (1979) Rotaviral immunity in gnotobiotic calves: heterologous resistance to human virus induced by bovine virus. Science 203, 548–550.

    CAS  PubMed  Google Scholar 

  77. Zissis, G., Lambert, J. P., Marbehant, P., et al. (1983) Protection studies in colostrum-deprived piglets of a bovine rotavirus vaccine candidate using human rotavirus strains for challenge. J. Infect. Dis. 142, 439–441.

    Google Scholar 

  78. Delem, A., Lobmann, M., and Zygraich, N. (1984) A bovine rotavirus developed as a candidate for use in humans. J. Biol. Stand. 12, 443–445.

    CAS  PubMed  Google Scholar 

  79. Vesikari, T., Kapikian, A., Delem, A., and Zissis, G. (1986) A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. J. Infect. Dis. 153, 832–839.

    CAS  PubMed  Google Scholar 

  80. Vesikari, T., Isolauri, E., Delem, A., et al. (1983) Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet 11, 807–811.

    Google Scholar 

  81. Vesikari, T., Isolauri, E., Delem, A., et al. (1985) Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J. Pediatr. 107, 189–194.

    CAS  PubMed  Google Scholar 

  82. Vesikari, T. (1996) Trials of oral bovine and rhesus rotavirus vaccines in Finland: a historical account and present status. Arch. Virol. 12, 177–186

    Google Scholar 

  83. DeMol, P., Zissis, G., Butzler, J. P., et al. (1986) Failure of live, attenuated and rotavirus vaccine. Lancet ii, 108.

    Google Scholar 

  84. Hanlon, P., Hanlon, K., Marsh, V., et al. (1987) Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1, 1342–1345.

    CAS  PubMed  Google Scholar 

  85. Lanata, C. F., Black, R. E., deAguila, R., et al. (1989) Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J. Infect. Dis. 159, 452–459.

    CAS  PubMed  Google Scholar 

  86. Bernstein, D. I., Smith, V. E., Sander, D. S., et al. (1990) Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J. Infect. Dis. 162, 1055–1062.

    CAS  PubMed  Google Scholar 

  87. Kapikian, A., Midthun, K., Hoshino, Y., et al. (1985) Rhesus rotavirus: a candidate vaccine for prevention of human rotavirus disease, in Molecular and Chemical Basis of Resistance to Parasitic, Bacterial, and Viral Diseases ( Lerner, R. A., Charnock, R. M., and Brown, F., eds.), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 357–367.

    Google Scholar 

  88. Bell, L. M., Clark, H. F., O’Brien, E. A., et al. (1987) Gastroenteritis caused by a human rotavirus (serotype 3) in a suckling mouse model. Proc. Soc. Exp. Biol. Med. 184, 127–132.

    CAS  PubMed  Google Scholar 

  89. Riepenhoff-Talty, M., Schaekel, K., Clark, H. F., et al. (1993) Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr. Res. 33, 394–399.

    CAS  PubMed  Google Scholar 

  90. Perez-Schael, I., Garcia, D., Gonzolez, M., et al. (1990) Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J. Med. Virol. 30, 219–229.

    CAS  PubMed  Google Scholar 

  91. Vesikari, T., Rautanen, T., Varis, T., et al. (1990) Rhesus rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age. Am. J. Dis. Child. 144, 285–289.

    CAS  PubMed  Google Scholar 

  92. Perez-Schael, I., Gonzalez, M., Daoud, N., et al. (1987) Reactogenicity and antigenicity of the rhesus rotavirus vaccine in Venezuelan children. J. Infect. Dis. 155, 334–338.

    CAS  PubMed  Google Scholar 

  93. Santosham, M., Letson, G. W., Wolff, M., et al. (1991) A field study of the safety and efficacy of two candidate rotavirus vaccines in a native American population. J. Infect. Dis. 163, 483–487.

    CAS  PubMed  Google Scholar 

  94. Christy, C., Madore, H. P., Pichichero, M. E., et al. (1988) Field trial of rhesus rotavirus vaccine in infants. Pediatr. Infect. Dis. J. 7, 647–650.

    Google Scholar 

  95. Rennels, M. B., Losonsky, G. A., Young, A. E., et al. (1990) An efficacy trail of the rhesus rotavirus vaccine in Maryland. Am. J. Dis. Child. 144, 601–604.

    CAS  PubMed  Google Scholar 

  96. Dongmei, C., Zhisheng, B., Su, L., et al. (1994) Preliminary observation of reaction and serological efficacy of strain LLR-85–37 of oral rotavirus live vaccine. Chinese J. Biol. 7, 53–56.

    Google Scholar 

  97. Vesikari, T., Ruuska, T., Koivu, H-P, et al. (1991) Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants. Pediatr. Infect. Dis. J. 10, 912–917.

    CAS  PubMed  Google Scholar 

  98. Bernstein, D. I., Smith, V. E., Sherwood, J. R., et al. (1998) Safety and immunogenicity of live, attenuated human rotavirus vaccine 89–12. Vaccine 16, 381–387.

    CAS  PubMed  Google Scholar 

  99. Hoshino, Y., Wyatt, R., Greenberg, H., et al. (1984) Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J. Infect. Dis. 149, 694–702.

    CAS  PubMed  Google Scholar 

  100. Gorziglia, M., Larralde, G., Kapikian, A., et al. (1990) Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4. Proc. Natl. Acad. Sci. USA 87, 7155–7159.

    CAS  PubMed  Google Scholar 

  101. Offit, P. A. and Clark, H. F. (1985) Maternal antibody-mediated protection against gastroenteritis due to rotavirus in newborn mice is dependent on both serotype and titer of antibody. J. Infect. Dis. 152, 1152–1158.

    CAS  PubMed  Google Scholar 

  102. Clark, H. F. and Offit, P. A. (1992) Rotavirus vaccines, in Vaccines, 2nd ed. ( Plotkin, S. and Mortimer, E., eds.). W. B. Saunders, Philadelphia, pp. 809–822.

    Google Scholar 

  103. Velazquez, F. R., Matson, D. O., Clava, J. J., et al. (1996) Rotavirus infection in infants as protection against subsequent infections. N. Engl. J. Med. 335, 1022–1028.

    CAS  PubMed  Google Scholar 

  104. Ward, R. L., Knowlton, D. R., Zito, E. T., et al. (1997) Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. J. Infect. Dis. 176, 570–577.

    CAS  PubMed  Google Scholar 

  105. Santosham, M., Moulton, L. H., Reid, R., et al. (1997) Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J. Pediatr. 131, 632–638.

    CAS  PubMed  Google Scholar 

  106. Jin, Q., Ward, R. L., Knowlton, D. R., et al. (1996) Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses. Arch. Virol. 141, 2057–2076.

    CAS  PubMed  Google Scholar 

  107. Wen, L., Nakayama, M., Yamanishi, Y., et al. (1997) Genetic variation in the VP7 gene of human rotavirus serotype 3 (G3 type) isolated in China and Japan. Arch. Virol. 142, 1481–1489.

    CAS  PubMed  Google Scholar 

  108. Gerna, G., Sarasini, A., Matteo, A., et al. (1988) Identification of two subtypes of serotype 4 human rotavirus by using VP7 specific neutralizing monoclonal antibodies. J. Clin. Microbiol. 26, 1388–1392.

    CAS  PubMed  Google Scholar 

  109. Aijaz, S., Gowda, K., Jagannath, H. V., et al. (1996) Epidemiology of symptomatic human rotaviruses in Bangalore and Mysore, India, from 1988 to 1994 as determined by electropherotype, subgroup and serotype analysis. Arch. Virol. 141, 715–726.

    CAS  PubMed  Google Scholar 

  110. Clark, H. F., Welsko, D., and Offit, P. (1992) Infant responses to bovine WC3 reassortants containing human rotavirus VP7, VP4, or VP7 + VP4 [abstract], in Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy (Anaheim, CA). Washington, DC, American Society for Microbiology, p. 343.

    Google Scholar 

  111. Vesikari, T., Ruuska, T., Green, K. Y., et al. (1992) Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity. Pediatr. Infect. Dis. J. 11, 535–542.

    CAS  PubMed  Google Scholar 

  112. Hoshino, Y. and Kapikian, A. (1994) Rotavirus antigens. Curr. Top. Microbiol. Immunol. 185, 179–227.

    CAS  PubMed  Google Scholar 

  113. Gouvea, V., DeCastro, L., Timenitsky, M-CST, et al. (1994) Rotavirus serotype G5 associated with diarrhea in Brazilian children. J. Clin. Microbiology 32, 1408, 1409.

    Google Scholar 

  114. Clark, H. F., Hoshino, Y., Bell, L., et al. (1987) Rotavirus isolate WI61 representing a presumptive new human serotype. J. Clin. Microbiol. 25, 1757–1762.

    CAS  PubMed  Google Scholar 

  115. Cicerello, H. G., Das, B. K., Gupta, A., et al. (1994) High prevalence of rotavirus infection among neonates born at hospitals in Delhi, India: predisposition of newborns for infection with unusual rotavirus. Pediatr. Infect. Disease J. 13, 720–724.

    Google Scholar 

  116. Renneis, M. B., Glass, R. I., Dennely, P. H., et al. (1996) Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines—report of the national multicenter trial. Pediatrics 97, 7–13.

    Google Scholar 

  117. National Communicable Diseases Centers (1997) Rotavirus vaccines for the prevention of rotavirus diarrhea in children: recommendations of the Advisory Committee on Immunization Practices (ACIP), U. S. Government Printing Office, Washington, D. C.

    Google Scholar 

  118. Dagan, R., Kassio, I., Sarov, B., et al. (1992) Safety and immunogenicity of oral tetravalent human-rhesus reassortant rotavirus vaccine in neonates. Ped. Infect. Dis. J. 11, 991–996.

    CAS  Google Scholar 

  119. Joensuu, J., Koskenniemi, E., Pang, X., and Vesikari, T. (1997) Randomized placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 350, 1205–1209.

    CAS  PubMed  Google Scholar 

  120. Lanata, C. F., Midthun, K., Black, R. E., et al. (1996) Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J. Infect. Dis. 174, 268–275.

    CAS  PubMed  Google Scholar 

  121. Linhares, A. C., Gabbay, Y. B., Mascarenhas, J. D. P., et al. (1996) Immunogenicity, safety, and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belem, Brazil. Bull. WHO 74, 491–500.

    CAS  PubMed  Google Scholar 

  122. Perez-Schael, I., Guntinas, M. J., Perez, M., et al. (1997) Efficacy of the rhesus rotavirusbased quadrivalent vaccine in infants and young children in Venezuela. N. Engl. J. Med. 337, 1181–1187.

    CAS  PubMed  Google Scholar 

  123. Wright, P. F., King, J., Araki, K., et al. (1991) Simultaneous administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children. J. Infect. Dis. 164, 271–276.

    CAS  PubMed  Google Scholar 

  124. Kobayashi, M., Thompson, J., Tollefson, S. J., et al. (1994) Tetravalent rhesus rotavirus vaccine in young infants. J. Infect. Dis. 170, 1260–1263.

    CAS  PubMed  Google Scholar 

  125. Clark, H. F., Offit, P. A., Ellis, R. W., et al. (1996) WC3 reassortant vaccines in children. Brief review. Arch. Virol. 12, 187–198.

    CAS  Google Scholar 

  126. Clark, H. F., Borian, F. E., and Plotkin, S. A. (1990) Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3. J. Infect. Dis. 161, 1099–1104.

    CAS  PubMed  Google Scholar 

  127. Treanor, J., Clark, H. F., Pichichero, M., et al. (1995) Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants. Pediatr. Infect. Dis. J. 14, 301–307.

    CAS  PubMed  Google Scholar 

  128. Clark, H. F., White, C. J., Offit, P. A., et al. (1995) Preliminary evaluation of safety and efficacy of quadrivalent human-bovine reassortant rotavirus vaccine. Ped. Res. 37, 172A.

    Google Scholar 

  129. Makhene, M., Midthun, K., Karron, R., et al. (1995) Safety and immunogenicity of human-UK bovine rotavirus reassortants in adults and pediatric subjects, in Abstracts of the 5th Rotavirus Vaccine Workshop: Current Issues and Future Developments (Atlanta). Atlanta: Centers for Disease Control and Prevention.

    Google Scholar 

  130. Vodopija, I., Baklaic, Z., Vlatkovic, R., et al. (1986) Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain. Vaccine 4, 233–236.

    CAS  PubMed  Google Scholar 

  131. Giammanco, G., DeGrandi, V., Lupo, L., et al. (1988) Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine. Eur. J. Epidemiol. 4, 121–123.

    CAS  PubMed  Google Scholar 

  132. Migasena, S., Simasathien, S., Samakoses, R., et al. (1995) Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine 13, 168–174.

    CAS  PubMed  Google Scholar 

  133. Rennels, M. B., Ward, R. L., Mack, M. E., and Zito, E. T. (1996) Concurrent oral poliovirus and rhesus-human rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. J. Infect. Dis. 173, 306–313.

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. Paul A. Offit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Fred Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Vaccine Development, BioChem Pharma, Inc., Northborough, MA, USA

    Ronald W. Ellis PhD (Vice-President, General Manager) (Vice-President, General Manager)

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Offit, P.A., Clark, H.F. (1999). Rotavirus Vaccines. In: Ellis, R.W. (eds) Combination Vaccines. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-265-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-265-4_8

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-4802-4

  • Online ISBN: 978-1-59259-265-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation